← All indications
Spinal Stenosis
Narrowing of the spinal canal.
Drugs by status
Phase 4 trials (32)
- urea
- ketamine
- diphenhydramine
- betamethasone
- gabapentin
- limaprost
- nicardipine
- ropivacaine
- acetaminophen
- polydeoxyribonucleotide
- lidocaine
- teriparatide
- epinephrine
- celecoxib
- buprenorphine
- bupivacaine
- tramadol
- clonidine
- dexmedetomidine
- fentanyl
- triamcinolone
- methadone
- propoxyphene
- tranexamic acid
- morphine
- pregabalin
- metaxalone
- sodium chloride
- oxymorphone
- remifentanil
- +2 more
Phase 3 trials (6)
Phase 2 trials (5)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (34)
- Pfizer
- Endo Pharmaceuticals
- Yungjin Pharm. Co., Ltd.
- Rockefeller University
- Harvard University
- Dankook University
- University of Washington
- Hanyang University
- Henry Ford Health System
- Inje University
- Kyung Hee University
- Kaiser Permanente
- Northwestern University
- Oregon Health and Science University
- Seoul National University
- Stanford University
- University of Rochester
- Yonsei University
- Mayo Clinic
- University of California, San Francisco
- University of Colorado, Denver
- University of Ulsan
- Vanderbilt University
- Allina Health
- Chung-Ang University
- Ortopedkliniken, Kalmar, Sweden
- Hallym University
- Linkoping University
- Aristotle University of Thessaloniki
- Department of Veteran Affairs
- +4 more
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (15)
- Europainclinics z.ú.
- Marshfield Clinic Research Foundation
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Pittsburgh
- Cancer Research Network
- Johns Hopkins University
- Navamindradhiraj University
- University of Southern California
- Peking University
- Tsinghua University
- Taipei Veteran General hospital
- Istanbul Medipol University
- University of Sao Paulo
- North American Spine Society
- Vivex Biomedical, Inc.